Scholars Central

Conference abstractPublished 17 Sep 2018

Diabetic cardiomyopathy

Authors: Sibel Catirli Enar

Sisli Memorial Hospital Istanbul, Turkey

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetic cardiomyopathy is a clinical condition which is diagnosed when ventricular dysfunction occurs in the absence of atherosclerosis and hypertension in diabetic patients. Myocardial dysfunction is diastolic at the beginning, but in later stages contraction dysfunction develops and systolic dysfunction also occurs. Heart failure guidelines published in 2013 state that Diabetes Mellitus (DM) is now well recognized risk factor for development of heart failure independent of age, hypertension, obesity, hypercholesterolemia and coronary artery disease. Currently diagnosing diabetic cardiomyopathy is based on noninvasive imaging techniques. In DM, both gluco and lipo-toxicities are responsible for increasing oxidative stress and chronic inflammation which leads to micro-vasculopathy. Reduced coronary microcirculation leads to chronic myocardial ischemia which causes pathological cardiac re-modeling which in turn leads to subsequent Diastolic Dysfunction (DD). Both reduced Coronary Flow Reserve (CFR) and DD are associated with Left Ventricular (LV) concentric remodeling, hypertrophy, abnormalities of angiotensin-renin system and with endothelial dysfunction. Therefore, it is proposed that coronary microvascular damage plays a mechanistic role for DD. Myocardial fibrosis and collagen deposition are the primary structural changes observed in diabetic cardiomyopathy. Therefore, impaired LV function observed in diabetic patients can be the result of fibrosis and altered collagen structure. Left Ventricular Hypertrophy (LVH) has been associated with DM independent of other factors (such as obesity, hypertension, or age). Prevalence of DD in diabetic patients is high, ranging from 21% to 75%. Diastolic dysfunction is considered as the first marker of diabetic cardiomyopathy. Both LVH and DD can be demonstrable by echocardiographic techniques. Subclinical LV dysfunction in asymptomatic diabetic patients may be assessed by speckle tracking echocardiography. Subclinical LV longitudinal dysfunction is frequently observed in asymptomatic diabetes patients with normal ejection fraction. Diabetes is an independent risk factor for heart failure. Micro-vasculopathy, myocardial fibrosis and myocardial steatosis all play a role in the pathogenesis of diabetic cardiomyopthy. Echocardiography can demonstrate the functional changes in diabetes such as LVH, DD and myocardial longitudinal function.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Sibel Catirli Enar”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels